PAK1 and depressive symptom measurement: Additionally, PAK1 mRNA levels are altered in the prefrontal cortex and hippocampus of depressed subjects [59], and RT-PCR revealed reduced expression of TGFBR2 in the functional forebrain regions and hippocampus of rodent models of depression [60].